- Home
- GNSS vs PMVP Comparison
GNSS vs PMVP Comparison
Compare GNSS & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- PMVP
- Stock Information
- Founded
- GNSS 1992
- PMVP 2013
- Country
- GNSS United States
- PMVP United States
- Employees
- GNSS N/A
- PMVP N/A
- Industry
- GNSS Consumer Electronics/Appliances
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- GNSS Consumer Staples
- PMVP Health Care
- Exchange
- GNSS Nasdaq
- PMVP Nasdaq
- Market Cap
- GNSS 98.9M
- PMVP 55.1M
- IPO Year
- GNSS N/A
- PMVP 2020
- Fundamental
- Price
- GNSS $1.70
- PMVP $1.06
- Analyst Decision
- GNSS Strong Buy
- PMVP Strong Buy
- Analyst Count
- GNSS 3
- PMVP 1
- Target Price
- GNSS $5.33
- PMVP $5.00
- AVG Volume (30 Days)
- GNSS 109.6K
- PMVP 283.2K
- Earning Date
- GNSS 08-05-2025
- PMVP 08-07-2025
- Dividend Yield
- GNSS N/A
- PMVP N/A
- EPS Growth
- GNSS N/A
- PMVP N/A
- EPS
- GNSS N/A
- PMVP N/A
- Revenue
- GNSS $27,780,000.00
- PMVP N/A
- Revenue This Year
- GNSS $91.14
- PMVP N/A
- Revenue Next Year
- GNSS $75.44
- PMVP N/A
- P/E Ratio
- GNSS N/A
- PMVP N/A
- Revenue Growth
- GNSS N/A
- PMVP N/A
- 52 Week Low
- GNSS $1.46
- PMVP $0.81
- 52 Week High
- GNSS $4.04
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- GNSS 55.45
- PMVP 52.88
- Support Level
- GNSS $1.48
- PMVP $1.01
- Resistance Level
- GNSS $1.60
- PMVP $1.12
- Average True Range (ATR)
- GNSS 0.10
- PMVP 0.08
- MACD
- GNSS 0.03
- PMVP -0.00
- Stochastic Oscillator
- GNSS 84.38
- PMVP 23.26
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.